Clinical Trials Browser

Phase 2 × Oligometastatic Prostate Carcinoma × 1 year × Clear all

NCT06369610 2025-11-14

Risk Stratified De-escalated Hormone Therapy With Radiation Therapy for the Treatment of Prostate Cancer

Phase 2 Recruiting

Oligometastatic Prostate Carcinoma